CRISPR Therapeutics AG SEC filings CRSP
CRISPR Therapeutics AG has 880 filings in SEC EDGAR's recent list, going back to May 13, 2016. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 19, 2026 | Oct 19, 2026 |
| 10-Q | Quarterly report | Aug 3, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| S-8 | Employee stock plan registration | Jun 5, 2026 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
| 10-Q | Quarterly report | May 4, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 4, 2026 | May 4, 2026 |
| ARS | Annual report to shareholders | Apr 21, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEF 14A | Proxy statement | Apr 21, 2026 | Jun 4, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 2, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 16, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Other events
|
Mar 11, 2026 | Mar 10, 2026 |
| 10-K | Annual report | Feb 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Other events
|
Oct 15, 2025 | Oct 15, 2025 |
| 424B5 | Prospectus supplement | Oct 15, 2025 | — |
| 10-Q | Quarterly report | Aug 4, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Other events
|
Jun 26, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 9, 2025 | Jun 5, 2025 |
| 424B5 | Prospectus supplement | May 19, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
May 19, 2025 | May 19, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 16, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 16, 2025 | — |
| DEF 14A | Proxy statement | Apr 16, 2025 | Jun 5, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 3, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 26, 2025 | Mar 24, 2025 |
| 10-K | Annual report | Feb 11, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2025 | Feb 11, 2025 |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2024 | Nov 5, 2024 |
| S-3ASR | Automatic shelf registration | Aug 5, 2024 | — |
| S-8 | Employee stock plan registration | Aug 5, 2024 | — |
| 10-Q | Quarterly report | Aug 5, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2024 | Aug 5, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 3, 2024 | May 30, 2024 |
| 8-K |
Current report
Officer or director change
|
May 23, 2024 | May 23, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| ARS | Annual report to shareholders | Apr 9, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 9, 2024 | — |
| DEF 14A | Proxy statement | Apr 9, 2024 | May 30, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 27, 2024 | May 30, 2024 |
| 10-K | Annual report | Feb 21, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 21, 2024 | Feb 21, 2024 |
| 8-K |
Current report
Material agreement
|
Feb 13, 2024 | Feb 13, 2024 |
| 424B5 | Prospectus supplement | Feb 13, 2024 | — |
| 8-K |
Current report
Other events
|
Feb 13, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Other events
|
Jan 16, 2024 | Jan 16, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 19, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Other events
|
Dec 15, 2023 | Dec 15, 2023 |
| 8-K |
Current report
Material agreement
|
Dec 13, 2023 | Dec 12, 2023 |
| 8-K |
Current report
Other events
|
Dec 8, 2023 | Dec 8, 2023 |
| 8-K |
Current report
Other events
|
Dec 4, 2023 | Dec 4, 2023 |
| 8-K |
Current report
Other events
|
Nov 16, 2023 | Nov 15, 2023 |
| 10-Q | Quarterly report | Nov 6, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 7, 2023 | Sep 4, 2023 |
| S-8 | Employee stock plan registration | Aug 7, 2023 | — |
| 10-Q | Quarterly report | Aug 7, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 9, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 9, 2023 | Jun 8, 2023 |
| DEFA14A | Additional proxy material | May 18, 2023 | — |
| 10-Q | Quarterly report | May 8, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 8, 2023 | May 8, 2023 |
| ARS | Annual report to shareholders | Apr 26, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2023 | — |
| DEF 14A | Proxy statement | Apr 26, 2023 | — |
| PRE 14A | Preliminary proxy statement | Apr 10, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 3, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 29, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 27, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 14, 2023 | Mar 9, 2023 |
| 10-K | Annual report | Feb 21, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 21, 2023 | Feb 21, 2023 |
| 10-Q | Quarterly report | Nov 1, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Officer or director change
|
Oct 27, 2022 | Oct 27, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 27, 2022 | Sep 27, 2022 |
| S-8 | Employee stock plan registration | Aug 8, 2022 | — |
| 10-Q | Quarterly report | Aug 8, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| UPLOAD | Letter from the SEC | Jul 13, 2022 | — |
| CORRESP | Letter to the SEC | Jun 23, 2022 | — |
| 8-K |
Current report
Other events
|
Jun 21, 2022 | Jun 21, 2022 |
| UPLOAD | Letter from the SEC | Jun 13, 2022 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 13, 2022 | Jun 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 13, 2022 | Jun 11, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 12, 2022 | May 12, 2022 |
| 10-Q | Quarterly report | May 9, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| DEFA14A | Additional proxy material | Apr 25, 2022 | — |
| DEF 14A | Proxy statement | Apr 25, 2022 | Jun 9, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2022 | Jun 9, 2022 |
| 10-K | Annual report | Feb 15, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 15, 2022 | Feb 15, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 20, 2021 | Dec 14, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 22, 2021 | Nov 22, 2021 |
| 10-Q | Quarterly report | Nov 3, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2021 | Nov 3, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 14, 2021 | Oct 14, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 12, 2021 | Oct 12, 2021 |
| S-3ASR | Automatic shelf registration | Jul 29, 2021 | — |
| 10-Q | Quarterly report | Jul 29, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2021 | Jul 29, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 14, 2021 | Jun 10, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 11, 2021 | Jun 11, 2021 |
| 8-K |
Current report
Other events
|
Jun 2, 2021 | Jun 2, 2021 |
| DEFA14A | Additional proxy material | Apr 28, 2021 | — |
| DEF 14A | Proxy statement | Apr 28, 2021 | Jun 10, 2021 |
| 10-Q | Quarterly report | Apr 27, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
Apr 27, 2021 | Apr 27, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 20, 2021 | Apr 16, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 5, 2021 | Jun 10, 2021 |
| 10-K | Annual report | Feb 16, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 16, 2021 | Feb 16, 2021 |
| 8-K |
Current report
Other events
|
Jan 15, 2021 | Jan 15, 2021 |
| 424B5 | Prospectus supplement | Jan 15, 2021 | — |
| 8-K |
Current report
Other events
|
Dec 17, 2020 | Dec 15, 2020 |
| 8-K |
Current report
Other events
|
Dec 11, 2020 | Dec 11, 2020 |
| 424B5 | Prospectus supplement | Dec 11, 2020 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 7, 2020 | Dec 5, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 4, 2020 | Nov 4, 2020 |
| 10-Q | Quarterly report | Oct 28, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2020 | Oct 28, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 21, 2020 | Oct 21, 2020 |
| S-8 | Employee stock plan registration | Jul 27, 2020 | — |
| 10-Q | Quarterly report | Jul 27, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Jul 27, 2020 | Jul 27, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 2, 2020 | Jun 29, 2020 |
| 424B5 | Prospectus supplement | Jul 1, 2020 | — |
| 424B5 | Prospectus supplement | Jun 29, 2020 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 12, 2020 | Jun 11, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 12, 2020 | Jun 12, 2020 |
| DEFA14A | Additional proxy material | May 15, 2020 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 14, 2020 | May 14, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
May 11, 2020 | May 11, 2020 |
| 10-Q | Quarterly report | Apr 28, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
Apr 28, 2020 | Apr 28, 2020 |
| DEFA14A | Additional proxy material | Apr 24, 2020 | — |
| DEF 14A | Proxy statement | Apr 24, 2020 | Jun 11, 2020 |
| D/A | Filing | Apr 10, 2020 | — |
| D | Filing | Apr 9, 2020 | — |
| PRE 14A | Preliminary proxy statement | Mar 31, 2020 | Jun 11, 2020 |
| 8-K |
Current report
Other events
|
Mar 31, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 26, 2020 | Feb 26, 2020 |
| 10-K | Annual report | Feb 12, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2020 | Feb 12, 2020 |
| 8-K |
Current report
Officer or director change
|
Jan 29, 2020 | Jan 26, 2020 |
| 8-K |
Current report
Agreement ended, Officer or director change
|
Dec 27, 2019 | Dec 27, 2019 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets
|
Dec 16, 2019 | Dec 13, 2019 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 22, 2019 | Nov 19, 2019 |
| 424B5 | Prospectus supplement | Nov 21, 2019 | — |
| 424B5 | Prospectus supplement | Nov 19, 2019 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 19, 2019 | Nov 19, 2019 |
| 10-Q | Quarterly report | Oct 28, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2019 | Oct 28, 2019 |
| 8-K |
Current report
Material agreement
|
Aug 30, 2019 | Aug 30, 2019 |
| 424B5 | Prospectus supplement | Aug 30, 2019 | — |
| S-8 | Employee stock plan registration | Jul 29, 2019 | — |
| 10-Q | Quarterly report | Jul 29, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2019 | Jul 29, 2019 |
| 8-K |
Current report
Other events
|
Jun 26, 2019 | Jun 25, 2019 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 13, 2019 | Jun 11, 2019 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 6, 2019 | Jun 6, 2019 |
| DEFA14A | Additional proxy material | Apr 30, 2019 | — |
| DEF 14A | Proxy statement | Apr 30, 2019 | Jun 11, 2019 |
| UPLOAD | Letter from the SEC | Apr 30, 2019 | — |
| 10-Q | Quarterly report | Apr 29, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2019 | Apr 29, 2019 |
| CORRESP | Letter to the SEC | Apr 29, 2019 | — |
| PRER14A | Filing | Apr 29, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2019 | — |
| CORRESP | Letter to the SEC | Apr 23, 2019 | — |
| PRER14A | Filing | Apr 23, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 19, 2019 | — |
| PRE 14A | Preliminary proxy statement | Apr 9, 2019 | Jun 11, 2019 |
| 10-K | Annual report | Feb 25, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 25, 2019 | Feb 25, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2019 | Feb 25, 2019 |
| CT ORDER | Filing | Nov 30, 2018 | — |
| 8-K |
Current report
Other events
|
Nov 9, 2018 | Nov 8, 2018 |
| 424B5 | Prospectus supplement | Nov 9, 2018 | — |
| 8-K |
Current report
Results of operations
|
Nov 7, 2018 | Nov 7, 2018 |
| 10-Q | Quarterly report | Nov 7, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 10, 2018 | Oct 10, 2018 |
| 424B5 | Prospectus supplement | Sep 24, 2018 | — |
| 8-K |
Current report
Material agreement
|
Sep 24, 2018 | Sep 24, 2018 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 21, 2018 | Sep 19, 2018 |
| 424B5 | Prospectus supplement | Sep 21, 2018 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CRSP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Zug
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1674416
- Former names
- CRISPR Therapeutics AG (until Nov 2, 2026)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.